risperidone has been researched along with deramciclane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Hietala, J; Kanerva, H; Kilkku, O; Kuoppamäki, M; Någren, K; Syvälahti, E; Vilkman, H | 1 |
2 other study(ies) available for risperidone and deramciclane
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration--a positron emission tomography study.
Topics: Administration, Oral; Adult; Animals; Camphanes; Cerebral Cortex; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Male; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin Antagonists; Tomography, Emission-Computed | 1999 |